Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Transcutaneous Spinal Cord Stimulation for Motor Recovery After Spinal Cord Injury

13 de novembro de 2026 atualizado por: Dr. Gabriel Zeilig

Restoring Upper and Lower Extremity Functions in Persons With Spinal Cord Injury by Transcutaneous Spinal Cord Stimulation

This study will examine the safety, feasibility, and potential benefits of transcutaneous spinal cord stimulation (scTS) combined with activity-based training in people with spinal cord injury.

The study will include 10 adults with chronic, incomplete spinal cord injury. Electrical stimulation will be delivered through electrodes placed on the skin over different regions of the spinal cord, while participants perform exercises involving the arms, hands, trunk, and legs.

Participants will undergo initial assessments, individualized stimulation mapping, and 80 training sessions, followed by final assessments. Researchers will evaluate changes in motor function, muscle activity, psychological well-being, autonomic function, and quality of life. Safety and tolerability will also be monitored throughout the study.

Visão geral do estudo

Status

Ainda não está recrutando

Condições

Intervenção / Tratamento

Descrição detalhada

This prospective, single-arm, within-subject exploratory study will enroll 10 adults aged 18-65 years with chronic incomplete cervical or thoracic spinal cord injury.

The study includes four phases: (1) baseline assessments over approximately two months; (2) stimulation mapping and optimization over approximately 0.5-1 month to identify individualized stimulation parameters; (3) 80 sessions of multisegment transcutaneous spinal cord stimulation combined with activity-based training, delivered 3-5 days per week over approximately 4-7 months; and (4) follow-up assessments.

The intervention targets upper and lower extremity function, trunk control, standing, and stepping. Motor performance will be assessed primarily using the Neuromuscular Recovery Scale (NRS). Additional assessments will examine muscle activation using electromyography (EMG), psychological symptoms, autonomic function, neurological status, spasticity, functional independence, and quality of life.

Intermediate assessments will be conducted during the intervention, including after 40 training sessions. Safety, adverse events, and feasibility will be evaluated throughout the study.

Tipo de estudo

Intervencional

Inscrição (Estimado)

10

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Locais de estudo

      • Ramat Gan, Israel
        • Sheba Medical Center
        • Contato:
        • Subinvestigador:
          • Einat Haber, M.D.

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos a 65 anos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  1. At least 18 years of age.
  2. Non-progressive cervical or thoracic (>T10) spinal cord injury (SCI), with the ability to voluntarily move at least three joints below the injury level.
  3. At least 6 months post spinal cord injury.
  4. Stable medical condition.
  5. Neuromuscular Recovery Scale (NRS) score <4C on any upper extremity, trunk, or standing/stepping item.

Exclusion Criteria:

  1. Ventilator dependence.
  2. Untreated or unstable fracture or pressure ulcer.
  3. Untreated psychiatric disorder or ongoing drug abuse.
  4. Cardiac, respiratory, bladder, renal, or other medical disorder that may interfere with the study.
  5. Skeletal muscle Botox injections within the previous 6 months.
  6. Previous nerve or tendon transfer of the arms or legs.
  7. Any implanted pump (e.g., baclofen pump or pain pump).
  8. Unable or unwilling to discontinue anti-spasticity medications.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: N / D
  • Modelo Intervencional: Atribuição de grupo único
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Multisegment scTS + Activity-Based Training

Participants will receive individualized multisegment transcutaneous spinal cord stimulation (scTS) combined with activity-based training targeting upper and lower extremity function, trunk control, standing, and stepping. The intervention will consist of 80 training sessions, delivered 3-5 days per week over approximately 4-7 months, with sessions lasting up to 2 hours.

Non-invasive electrical stimulation delivered through surface electrodes placed over multiple spinal levels using the NeoStim-5 system. Stimulation sites and parameters will be individually optimized to facilitate motor activation of the upper extremities, trunk, and lower extremities during activity-based training.

Individualized, task-specific rehabilitation training targeting voluntary control of the hands, arms, trunk, and legs, including seated activities, standing, and stepping. Training will be provided by rehabilitation staff and combined with transcutaneous spinal cord stimulation.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Motor Function (NRS)
Prazo: Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).

Changes in motor performance assessed using the Neuromuscular Recovery Scale (NRS), which evaluates movement quality and the level of assistance required during upper extremity, trunk, standing, and stepping tasks. Changes in individual task ratings will be assessed across study time points.

Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).
Safety
Prazo: From enrollment through the final study assessment (approximately 7-10 months per participant).

Incidence of adverse events and equipment-related complications during the study. Adverse events will be categorized by severity, relatedness to study procedures, and expectedness.

From enrollment through the final study assessment (approximately 7-10 months per participant).

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Change in Surface EMG Amplitude During Functional Motor Tasks
Prazo: Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).

Changes in surface electromyography (EMG) signal amplitude during functional motor tasks involving upper extremity, trunk, and lower extremity muscles.

Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).
Depression (PHQ-9)
Prazo: Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).

Changes in depressive symptoms measured using the 9-item Patient Health Questionnaire (PHQ-9). Total scores range from 0 to 27, with higher scores indicating greater depressive symptom severity.

Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).
Anxiety (GAD-7)
Prazo: Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).

Changes in anxiety symptoms measured using the 7-item Generalized Anxiety Disorder scale (GAD-7). Total scores range from 0 to 21, with higher scores indicating greater anxiety symptom severity.

Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).
PTSD (PCL-5)
Prazo: Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training)

Changes in self-reported post-traumatic stress symptoms measured using the PTSD Checklist for DSM-5 (PCL-5). Total scores range from 0 to 80, with higher scores indicating greater symptom severity.

Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training)
PTSD (CAPS-5)
Prazo: Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).

Changes in clinician-rated post-traumatic stress symptom severity measured using the CAPS-5. The total severity score ranges from 0 to 80, with higher scores indicating greater symptom severity.

Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).
Change in ISNCSCI Total Motor Score
Prazo: Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)

Change in motor function assessed using the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI). The total motor score ranges from 0 to 100, with higher scores indicating better motor function.

Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
Change in Modified Ashworth Scale (MAS) Score
Prazo: Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)

Change in muscle spasticity assessed by a clinician using the Modified Ashworth Scale, which grades resistance to passive movement.

Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
Change in Spinal Cord Injury Spasticity Evaluation Tool (SCI-SET) Score
Prazo: Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)

Change in the self-reported impact of spasticity on daily activities, assessed using the SCI-SET questionnaire covering the preceding seven days.

Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
Change in Autonomic Dysfunction Following Spinal Cord Injury (ADFSCI) Questionnaire Score
Prazo: Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)

Change in frequency and severity of symptoms associated with blood pressure instability, assessed using the 24-item ADFSCI questionnaire.

Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
Change in Modified Functional Reach Test Distance
Prazo: Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)

Change in maximum forward reaching distance while seated, measured using the Modified Functional Reach Test

Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
Change in Activity-Based Balance Level (ABLE) Sitting Subscale Score
Prazo: Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)

Change in sitting balance assessed using the seven items of the ABLE sitting subscale, with a maximum score of 32.

Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

1 de janeiro de 2027

Conclusão Primária (Estimado)

1 de janeiro de 2029

Conclusão do estudo (Estimado)

1 de janeiro de 2030

Datas de inscrição no estudo

Enviado pela primeira vez

8 de novembro de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

13 de novembro de 2026

Primeira postagem (Real)

16 de novembro de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

16 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

13 de novembro de 2026

Última verificação

1 de novembro de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • SHEBA-26-3283-GZ-CTIL

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .